We demonstrated that GSTM2 protects against hepatic steatosis by inhibiting excess fat accumulation by interacting with and suppressing activation of apoptosis signal-regulating kinase1 (ASK1) and subsequent p38-JNK signalling, besides its antioxidant capacity. Here, MAP3K5 is linked to fatty liver disease.